Reported 31,323 shares, down 688,831 (95.7%) from the prior quarter.
Reported value -94.9%; share count -95.7% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 8680000 |
| 2022-03-31 | 2869000 |
| 2022-06-30 | 1980000 |
| 2022-09-30 | 100000 |
| 2022-12-31 | 117190 |
| 2023-03-31 | 500583 |
| 2023-06-30 | 186992 |
| 2023-09-30 | 361988 |
| 2023-12-31 | 536520 |
| 2024-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2024 | Reduced | 0 | -204,778 (-100.0%) | 0 | $0 | 2024-05-15 | |
| Q4 2023 | Added | 204,778 | +58,815 (40.3%) | < 0.01% | $536,520 | 2024-02-13 | |
| Q3 2023 | Added | 145,963 | +74,043 (103.0%) | < 0.01% | $361,988 | 2023-11-15 | |
| Q2 2023 | Reduced | 71,920 | -132,400 (-64.8%) | < 0.01% | $186,992 | 2023-08-14 | |
| Q1 2023 | Added | 204,320 | +169,022 (478.8%) | < 0.01% | $500,583 | 2023-05-15 | |
| Q4 2022 | Added | 35,298 | +3,975 (12.7%) | < 0.01% | $117,190 | 2023-02-14 | |
| Q3 2022 | Reduced | 31,323 | -688,831 (-95.7%) | < 0.01% | $100,000 | 2022-11-14 | |
| Q2 2022 | Added | 720,154 | +157,660 (28.0%) | < 0.01% | $1,980,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 562,494 | -135,886 (-19.5%) | < 0.01% | $2,869,000 | 2022-05-13 | |
| Q4 2021 | Added | 698,380 | +284,615 (68.8%) | < 0.01% | $8,680,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
76 managers reported GRAPHITE BIO INC for Q3 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Samsara BioCapital LLC | Unchanged | 8,459,314 | 0 | 6.25% | $26,816,000 | 6 qtrs |
| FMR LLC | Reduced | 4,872,758 | -354,702 | < 0.01% | $15,446,643 | 6 qtrs |
| EcoR1 Capital LLC | Added | 1,582,135 | +419,956 | 0.15% | $5,015,000 | 4 qtrs |
| Avidity Partners Management LP | Added | 1,575,000 | +865,000 | 0.1% | $4,993,000 | 6 qtrs |
| CITADEL ADVISORS LLC | Reduced | 1,274,047 | -45,789 | < 0.01% | $4,039,000 | 6 qtrs |
| VANGUARD GROUP INC | Added | 1,200,282 | +136,371 | < 0.01% | $3,805,000 | 6 qtrs |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 1,100,000 | 0 | 0.43% | $3,487,000 | 2 qtrs |
| FEDERATED HERMES INC | Added | 1,057,983 | +1,675 | < 0.01% | $3,353,000 | 6 qtrs |
| ORBIMED ADVISORS LLC | Unchanged | 848,412 | 0 | 0.05% | $2,689,000 | 6 qtrs |
| Board of Trustees of The Leland Stanford Junior University | Unchanged | 703,071 | 0 | 0.14% | $2,229,000 | 6 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2022
- Filed
- November 14, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 23,423
- Shared
- 0
- None
- 7,900
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.